Loading the content... Loading depends on your connection speed!

Algorithm Information

Erlotinib (Tarceva) Treatment | Risk Factors for Gastrointestinal Perforation

MyLikes

MyPaths

Purpose:
To identify risk factors for gastrointestinal perforation in a patient being treated with erlotinib (Tarceva).
Specialty
  • Hematology Oncology
    Gastroenterology
Objective
  • Risk factors
  • Adverse effects
ICD-10
  • T45.1
MyPaths
Cancel
Create Path
Create
Cancel
Create Note
Save
Erlotinib (Tarceva) Treatment | Risk Factors for Gastrointestinal Perforation
Cancel
Save Data
Save